Report Detail

Pharma & Healthcare Global Ruminant Vaccines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4745913
  • |
  • 28 September, 2026
  • |
  • Global
  • |
  • 130 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Ruminant Vaccines market size was valued at US$ 2898 million in 2025 and is forecast to a readjusted size of US$ 4326 million by 2032 with a CAGR of 6.0% during review period.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 315%.
This report is a detailed and comprehensive analysis for global Ruminant Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ruminant Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ruminant Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ruminant Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ruminant Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ruminant Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ruminant Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ruminant Vaccines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Other
Market segment by Application
Cattle
Sheep
Other
Major players covered
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ruminant Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ruminant Vaccines, with price, sales quantity, revenue, and global market share of Ruminant Vaccines from 2021 to 2026.
Chapter 3, the Ruminant Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ruminant Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ruminant Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ruminant Vaccines.
Chapter 14 and 15, to describe Ruminant Vaccines sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Ruminant Vaccines Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Live Attenuated Vaccines
    • 1.3.3 Inactivated Vaccines
    • 1.3.4 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Ruminant Vaccines Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Cattle
    • 1.4.3 Sheep
    • 1.4.4 Other
  • 1.5 Global Ruminant Vaccines Market Size & Forecast
    • 1.5.1 Global Ruminant Vaccines Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Ruminant Vaccines Sales Quantity (2021-2032)
    • 1.5.3 Global Ruminant Vaccines Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Ruminant Vaccines Product and Services
    • 2.1.4 Merck Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Zoetis
    • 2.2.1 Zoetis Details
    • 2.2.2 Zoetis Major Business
    • 2.2.3 Zoetis Ruminant Vaccines Product and Services
    • 2.2.4 Zoetis Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Zoetis Recent Developments/Updates
  • 2.3 Boehringer Ingelheim
    • 2.3.1 Boehringer Ingelheim Details
    • 2.3.2 Boehringer Ingelheim Major Business
    • 2.3.3 Boehringer Ingelheim Ruminant Vaccines Product and Services
    • 2.3.4 Boehringer Ingelheim Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.4 Ceva
    • 2.4.1 Ceva Details
    • 2.4.2 Ceva Major Business
    • 2.4.3 Ceva Ruminant Vaccines Product and Services
    • 2.4.4 Ceva Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Ceva Recent Developments/Updates
  • 2.5 CAHIC
    • 2.5.1 CAHIC Details
    • 2.5.2 CAHIC Major Business
    • 2.5.3 CAHIC Ruminant Vaccines Product and Services
    • 2.5.4 CAHIC Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 CAHIC Recent Developments/Updates
  • 2.6 HVRI
    • 2.6.1 HVRI Details
    • 2.6.2 HVRI Major Business
    • 2.6.3 HVRI Ruminant Vaccines Product and Services
    • 2.6.4 HVRI Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 HVRI Recent Developments/Updates
  • 2.7 Ringpu Biology
    • 2.7.1 Ringpu Biology Details
    • 2.7.2 Ringpu Biology Major Business
    • 2.7.3 Ringpu Biology Ruminant Vaccines Product and Services
    • 2.7.4 Ringpu Biology Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Ringpu Biology Recent Developments/Updates
  • 2.8 Yebio
    • 2.8.1 Yebio Details
    • 2.8.2 Yebio Major Business
    • 2.8.3 Yebio Ruminant Vaccines Product and Services
    • 2.8.4 Yebio Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Yebio Recent Developments/Updates
  • 2.9 DHN
    • 2.9.1 DHN Details
    • 2.9.2 DHN Major Business
    • 2.9.3 DHN Ruminant Vaccines Product and Services
    • 2.9.4 DHN Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 DHN Recent Developments/Updates
  • 2.10 WINSUN
    • 2.10.1 WINSUN Details
    • 2.10.2 WINSUN Major Business
    • 2.10.3 WINSUN Ruminant Vaccines Product and Services
    • 2.10.4 WINSUN Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 WINSUN Recent Developments/Updates
  • 2.11 Elanco
    • 2.11.1 Elanco Details
    • 2.11.2 Elanco Major Business
    • 2.11.3 Elanco Ruminant Vaccines Product and Services
    • 2.11.4 Elanco Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Elanco Recent Developments/Updates
  • 2.12 Virbac
    • 2.12.1 Virbac Details
    • 2.12.2 Virbac Major Business
    • 2.12.3 Virbac Ruminant Vaccines Product and Services
    • 2.12.4 Virbac Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Virbac Recent Developments/Updates
  • 2.13 Jinyu Bio-Technology
    • 2.13.1 Jinyu Bio-Technology Details
    • 2.13.2 Jinyu Bio-Technology Major Business
    • 2.13.3 Jinyu Bio-Technology Ruminant Vaccines Product and Services
    • 2.13.4 Jinyu Bio-Technology Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Jinyu Bio-Technology Recent Developments/Updates
  • 2.14 ChengDu Tecbond
    • 2.14.1 ChengDu Tecbond Details
    • 2.14.2 ChengDu Tecbond Major Business
    • 2.14.3 ChengDu Tecbond Ruminant Vaccines Product and Services
    • 2.14.4 ChengDu Tecbond Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 ChengDu Tecbond Recent Developments/Updates
  • 2.15 CAVAC
    • 2.15.1 CAVAC Details
    • 2.15.2 CAVAC Major Business
    • 2.15.3 CAVAC Ruminant Vaccines Product and Services
    • 2.15.4 CAVAC Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 CAVAC Recent Developments/Updates
  • 2.16 Kyoto Biken Laboratories
    • 2.16.1 Kyoto Biken Laboratories Details
    • 2.16.2 Kyoto Biken Laboratories Major Business
    • 2.16.3 Kyoto Biken Laboratories Ruminant Vaccines Product and Services
    • 2.16.4 Kyoto Biken Laboratories Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Kyoto Biken Laboratories Recent Developments/Updates
  • 2.17 FATRO
    • 2.17.1 FATRO Details
    • 2.17.2 FATRO Major Business
    • 2.17.3 FATRO Ruminant Vaccines Product and Services
    • 2.17.4 FATRO Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 FATRO Recent Developments/Updates
  • 2.18 Vaksindo
    • 2.18.1 Vaksindo Details
    • 2.18.2 Vaksindo Major Business
    • 2.18.3 Vaksindo Ruminant Vaccines Product and Services
    • 2.18.4 Vaksindo Ruminant Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Vaksindo Recent Developments/Updates

3 Competitive Environment: Ruminant Vaccines by Manufacturer

  • 3.1 Global Ruminant Vaccines Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Ruminant Vaccines Revenue by Manufacturer (2021-2026)
  • 3.3 Global Ruminant Vaccines Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Ruminant Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Ruminant Vaccines Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Ruminant Vaccines Manufacturer Market Share in 2025
  • 3.5 Ruminant Vaccines Market: Overall Company Footprint Analysis
    • 3.5.1 Ruminant Vaccines Market: Region Footprint
    • 3.5.2 Ruminant Vaccines Market: Company Product Type Footprint
    • 3.5.3 Ruminant Vaccines Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ruminant Vaccines Market Size by Region
    • 4.1.1 Global Ruminant Vaccines Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Ruminant Vaccines Consumption Value by Region (2021-2032)
    • 4.1.3 Global Ruminant Vaccines Average Price by Region (2021-2032)
  • 4.2 North America Ruminant Vaccines Consumption Value (2021-2032)
  • 4.3 Europe Ruminant Vaccines Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Ruminant Vaccines Consumption Value (2021-2032)
  • 4.5 South America Ruminant Vaccines Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Ruminant Vaccines Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Ruminant Vaccines Sales Quantity by Type (2021-2032)
  • 5.2 Global Ruminant Vaccines Consumption Value by Type (2021-2032)
  • 5.3 Global Ruminant Vaccines Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Ruminant Vaccines Sales Quantity by Application (2021-2032)
  • 6.2 Global Ruminant Vaccines Consumption Value by Application (2021-2032)
  • 6.3 Global Ruminant Vaccines Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Ruminant Vaccines Sales Quantity by Type (2021-2032)
  • 7.2 North America Ruminant Vaccines Sales Quantity by Application (2021-2032)
  • 7.3 North America Ruminant Vaccines Market Size by Country
    • 7.3.1 North America Ruminant Vaccines Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Ruminant Vaccines Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Ruminant Vaccines Sales Quantity by Type (2021-2032)
  • 8.2 Europe Ruminant Vaccines Sales Quantity by Application (2021-2032)
  • 8.3 Europe Ruminant Vaccines Market Size by Country
    • 8.3.1 Europe Ruminant Vaccines Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Ruminant Vaccines Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ruminant Vaccines Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Ruminant Vaccines Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Ruminant Vaccines Market Size by Region
    • 9.3.1 Asia-Pacific Ruminant Vaccines Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Ruminant Vaccines Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Ruminant Vaccines Sales Quantity by Type (2021-2032)
  • 10.2 South America Ruminant Vaccines Sales Quantity by Application (2021-2032)
  • 10.3 South America Ruminant Vaccines Market Size by Country
    • 10.3.1 South America Ruminant Vaccines Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Ruminant Vaccines Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ruminant Vaccines Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Ruminant Vaccines Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Ruminant Vaccines Market Size by Country
    • 11.3.1 Middle East & Africa Ruminant Vaccines Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Ruminant Vaccines Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Ruminant Vaccines Market Drivers
  • 12.2 Ruminant Vaccines Market Restraints
  • 12.3 Ruminant Vaccines Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ruminant Vaccines and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ruminant Vaccines
  • 13.3 Ruminant Vaccines Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ruminant Vaccines Typical Distributors
  • 14.3 Ruminant Vaccines Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Ruminant Vaccines. Industry analysis & Market Report on Ruminant Vaccines is a syndicated market report, published as Global Ruminant Vaccines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Ruminant Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report